share_log

Haemonetics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Wellington Management Group LLP(6.44%),Wellington Group Holdings LLP(6.44%), etc.

美國血液技術 | SC 13G/A:超過5%持股股東披露文件(修正)-Wellington Management Group LLP(6.44%),Wellington Group Holdings LLP(6.44%)等

SEC announcement ·  02/08 10:26
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息